Shizuoka, Japan

Atushi Kajiyama


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 44(Granted Patents)


Company Filing History:


Years Active: 2003-2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Atushi Kajiyama: Innovator in Pharmaceutical Technology

Introduction

Atushi Kajiyama is a notable inventor based in Shizuoka, Japan. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of quick disintegrating tablets. His innovative work has led to the filing of multiple patents, showcasing his expertise and dedication to improving drug delivery systems.

Latest Patents

Kajiyama holds 2 patents, with his latest inventions focusing on quick disintegrating tablets for buccal cavity applications. One of his patents describes a method for creating drug-containing particles with a mean particle diameter of approximately 50 to 250 micrometers. These particles consist of a bitter-tasting drug and/or a drug of inferior fluidity, combined with a pharmaceutical preparation carrier obtained through spray drying. The invention aims to enhance the effectiveness of drug delivery by ensuring rapid disintegration in the buccal cavity.

Career Highlights

Throughout his career, Atushi Kajiyama has worked with prominent companies in the pharmaceutical industry, including Yamanouchi Pharmaceutical Company Ltd. and Astellas Pharma GmbH. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking advancements in drug formulation and delivery.

Collaborations

Kajiyama has collaborated with esteemed colleagues such as Tetsuya Tamura and Takao Mizumoto. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pharmaceutical field.

Conclusion

Atushi Kajiyama's work in developing quick disintegrating tablets represents a significant advancement in pharmaceutical technology. His patents and collaborations highlight his commitment to improving drug delivery systems, ultimately benefiting patients and healthcare providers alike.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…